Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Insulin (IN-105) in Type 1 Diabetes Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01035801
Recruitment Status : Terminated (This study was temporarily paused due to an unanticipated bioanalytical issue.)
First Posted : December 21, 2009
Last Update Posted : January 23, 2018
Information provided by (Responsible Party):
Biocon Limited

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : March 12, 2011
  Actual Study Completion Date : March 12, 2011